Translational Metabolism Research Laboratory
We are conducting a new research study to regulate blood sugar in adults with prediabetes. Participants must be age 18-55 years and have prediabetes. Participants cannot have diabetes, cardiovascular disease or be pregnant/nursing.
Participants may receive up to $1000 and information about their health.
This study is called Use of empagliflozin to treat prediabetes: a randomized, placebo-controlled, 13-week intervention trial. It is being conducted by Sean Newsom, Ph.D., and Matthew Robinson, Ph.D., Oregon State University and Samaritan Health Services.
To determine if you are eligible to participate in this study, please complete the following online survey:
If you are interested in learning more about this opportunity, please contact us at email@example.com.